Abstract
Primary amebic meningoencephalitis (PAM) is a necrotizing and hemorrhagic inflammation of the brain and meninges caused by Naegleria fowleri, a free-living thermophilic ameba of freshwater systems. PAM remains a neglected disease that disproportionately affects children in tropical and subtropical climates, with an estimated mortality rate of 95–98%. Due to anthropogenic climate change, the average temperature in the USA has increased by 0.72 to 1.06 °C in the last century, promoting the poleward spread of N. fowleri. PAM is often misdiagnosed as bacterial meningitis or viral encephalitis, which shortens the window for potentially life-saving treatment. Diagnosis relies on the patient’s history of freshwater exposure and the physician’s high index of suspicion, supported by cerebrospinal fluid studies. While no experimental trials have been conducted to assess the relative efficacy of treatment regimens, anti-amebic therapy with adjunctive neuroprotection is standard treatment in the USA. We performed a literature review and identified five patients from North America between 1962 and 2022 who survived PAM with various degrees of sequelae.
Similar content being viewed by others
Data availability
Information from case reports can be found on PubMed or Google Scholar. Data from the Waterborne Disease and Outbreak Surveillance System at CDC is available upon request. Interested parties should visit their website.
References
Ahmad Zamzuri M, Abd Majid F, Mihat M et al (2023) Systematic review of brain-eating amoeba: a decade update. Int J Environ Res Public Health 20:3021
Balczun C, Scheid PL (2017) Free-living amoebae as hosts for and vectors of intracellular microorganisms with public health significance. Viruses 9:1–18
Bhagwandeen SB, Carter RF, Naik KG, Levitt D (1975) A case of hartmannellid amebic meningoencephalitis in Zambia. Am J Clin Pathol 63:483–492
Blair B, Sarkar P, Bright KR et al (2008) Naegleria fowleri in well water. Emerg Infect Dis 14:1499–1501
Cao W (2021) Autopsy education and rate: effect of the COVID-19 pandemic. R I Med 104(10):21–25
Capewell LG, Harris AM, Yoder JS et al (2015) Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937–2013. J Pediatric Infect Dis Soc 4:e68–e75
Caruzo G, Cardozo J (2008) Primary amoebic meningoencephalitis: a new case from Venezuela. Trop Dr 38:256–257
Centers for Disease Control and Prevention (2023a) Case reports by state of exposure. https://www.cdc.gov/parasites/naegleria/state-map.html. Accessed 25 Sep 2023a
Centers for Disease Control and Prevention (2023b) Treatment | Naegleria fowleri. https://www.cdc.gov/parasites/naegleria/treatment-hcp.html. Accessed 30 Sep 2023b
Centers for Disease Control and Prevention (2022) Swimming precautions | Naegleria fowleri. https://www.cdc.gov/parasites/naegleria/swimming.html. Accessed 9 Oct 2023
Chao-Pellicer J, Arberas-Jiménez I, Fuchs F et al (2023) Repurposing of nitroxoline as an alternative primary amoebic meningoencephalitis treatment. Antibiotics 12:1280
Clavel A, Franco L, Letona S et al (1996) Primary amebic meningoencephalitis in a patient with AIDS: unusual protozoological findings. Clin Infect Dis 23:1314–1315
Cooper AM, Aouthmany S, Shah K, Rega PP (2019) Killer amoebas: primary amoebic meningoencephalitis in a changing climate. J Am Acad Physician Assist 32:30–35
Cope J (2013) Investigational drug available directly from CDC for the treatment of infections with free-living amebae. MMWR 62:666
Cope JR, Ali IK (2016) Primary amebic meningoencephalitis: what have we learned in the last five years? Curr Infect Dis Rep 18:1–11
Cope JR, Conrad DA, Cohen N et al (2016) Use of the novel therapeutic agent miltefosine for the treatment of primary amebic meningoencephalitis: report of one fatal and one surviving case. Clin Infect Dis 62:774–776
Cope JR, Murphy J, Kahler A et al (2018) Primary amebic meningoencephalitis associated with rafting on an artificial whitewater river: case report and environmental investigation. Clin Infect Dis 66:548–553
De Jonckheere JF (2011) Origin and evolution of the worldwide distributed pathogenic amoeboflagellate Naegleria fowleri. Infect Genet Evol 11:1520–1528
Dorlo TPC, Balasegaram M, Beijnen JH, de Vries PJ (2012) Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother 67:2576–2597
Dorsch MM, Cameron AS, Robinson BS (1983) The epidemiology and control of primary amoebic meningoencephalitis with particular reference to South Australia. Trans R Soc Trop Med Hyg 77:372–377
Fowler M, Carter RF (1965) Acute pyogenic meningitis probably due to Acanthamoeba sp.: a preliminary report. Br Med J 2:740–742
Gautam PL, Sharma S, Puri S et al (2012) A rare case of survival from primary amebic meningoencephalitis. Indian J Crit Care Med 16:34–36
Gharpure R, Bliton J, Goodman A et al (2021) Epidemiology and clinical characteristics of primary amebic meningoencephalitis caused by Naegleria fowleri: a global review. Clin Infect Dis 73:e19–e27
Gompf SG, Garcia C (2019) Lethal encounters: the evolving spectrum of amoebic meningoencephalitis. IDCases 15:e00524
Goswick SM, Brenner GM (2003) Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. Antimicrob Agents Chemother 47:524–528
Grace E, Asbill S, Virga K (2015) Naegleria fowleri: pathogenesis, diagnosis, and treatment options. Antimicrob Agents Chemother 59:6677–6681
Grate I (2006) Primary amebic meningoencephalitis: a silent killer. Canad J Emerg Med 8:365–369
Guarner J, Bartlett J, Shieh WJ et al (2007) Histopathologic spectrum and immunohistochemical diagnosis of amebic meningoencephalitis. Mod Pathol 20:1230–1237
Güémez A, García E (2021) Primary amoebic meningoencephalitis by Naegleria fowleri: pathogenesis and treatments. Biomolecules 11:1320
Hamaty E, Faiek S, Nandi M et al (2020) A fatal case of primary amoebic meningoencephalitis from recreational waters. Case Rep Crit Care 2020:e9235794
Hyam S, Undar S, Ha TKJ et al (2002) Oral miltefosine for Indian visceral leishmaniasis. NEJM 347:1739–1746
Irazuzta JE, Pretzlaff R, Rowin M et al (2000) Hypothermia as an adjunctive treatment for severe bacterial meningitis. Brain Res 881:88–97
Jain R, Prabhakar S, Modi M et al (2002) Naegleria meningitis: a rare survival. Neurol India 50:470–472
Jarolim KL, McCosh JK, Howard MJ, John DT (2000) A light microscopy study of the migration of Naegleria fowleri from the nasal submucosa to the central nervous system during the early stage of primary amebic meningoencephalitis in mice. J Parasitol 86:50–55
Kalra SK, Sharma P, Shyam K et al (2020) Acanthamoeba and its pathogenic role in granulomatous amebic encephalitis. Exp Parasitol 208:107788
Kemble SK, Lynfield R, DeVries AS et al (2012) Fatal Naegleria fowleri infection acquired in Minnesota: possible expanded range of a deadly thermophilic organism. Clin Infect Dis 54:805–809
Kim JH, Jung SY, Lee YJ et al (2008) Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri. Antimicrob Agents Chemother 52:4010–4016
Kranz J, Schmidt S, Lebert C et al (2018) The 2017 Update of the German clinical guideline on epidemiology, diagnostics, therapy, prevention, and management of uncomplicated urinary tract infections in adult patients. Part II: therapy and prevention. Urol Int 100:271–278
Laniado-Laborín R, Cabrales-Vargas MN (2009) Amphotericin B: side effects and toxicity. Rev Iberoam Micol 26:223–227
Laurie MT, White CV, Retallack H et al (2018) Functional assessment of 2,177 U.S. and international drugs identifies the quinoline nitroxoline as a potent amoebicidal agent against the pathogen Balamuthia mandrillaris. mBio 9:e02051–e02018
Lepur D, Kutleša M, Baršić B (2011) Induced hypothermia in adult community-acquired bacterial meningitis – more than just a possibility? J Infect 62:172–177
Linam WM, Ahmed M, Cope JR et al (2015) Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis. Pediatrics 135:e748
Lopez C, Budge P, Chen J et al (2012) Primary amebic meningoencephalitis: a case report and literature review. Pediatr Emerg Care 28:272–276
Marciano-Cabral F (1988) Biology of Naegleria spp. Microbiol Rev 52:114–133
Marciano-Cabral F, Cabral G (2003) Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 16:273–307
Marciano-Cabral F, Cabral GA (2007) The immune response to Naegleria fowleri amebae and pathogenesis of infection. FEMS Immunol Med Microbiol 51:243–259
Martinez AJ, Visvesvara GS (1991) Laboratory diagnosis of pathogenic free-living amoebas: Naegleria, Acanthamoeba, and Leptomyxid. Clin Lab Med 11:861–872
McIntyre LA, Fergusson DA, Hébert PC et al (2003) Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA 289:2992–2999
Milanez GD, Carlos KB, Adao ME et al (2023) Epidemiology of free-living amoebae infections in Africa: a review. Pathog Glob Health 117:527–534
Milanez GD, Masangkay FR, Martin IGL et al (2022) Epidemiology of free-living amoebae in the Philippines: a review and update. Pathog Glob Health 116:331–340
Moura H, Izquierdo F, Woolfitt AR et al (2015) Detection of biomarkers of pathogenic Naegleria fowleri through mass spectrometry and proteomics. J Eukaryot Microbiol 62:12–20
Mourvillier B, Tubach F, Van De Beek D et al (2013) Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA 310:2174–2183
Naber KG, Niggemann H, Stein G, Stein G (2014) Review of the literature and individual patients’ data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections. BMC Infect Dis 14:628
Nau R, Sörgel F, Eiffert H (2010) Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 23:858–883
Pellerin J, Edmond MB (2013) Infections associated with religious rituals. Int J Infect Dis 17:e945–e948
Piñero JE, Chávez-Munguía B, Omaña-Molina M, Lorenzo-Morales J (2019) Naegleria fowleri. Trends Parasitol 35:848–849
Polderman KH (2009) Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 37:S186–S202
Prachayasittikul V, Prachayasittikul S, Ruchirawat S, Prachayasittikul V (2013) 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications. Drug Des Devel Ther 7:1157–1178
Rajendran K, Anwar A, Khan NA, Siddiqui R (2017) Brain-eating amoebae: silver nanoparticle conjugation enhanced efficacy of anti-amoebic drugs against Naegleria fowleri. ACS Chem Neurosci 8:2626–2630
Roy SL, Metzger R, Chen JG et al (2014) Risk for transmission of Naegleria fowleri from solid organ transplantation. Am J Transplant 14:163–171
Schuster FL, Guglielmo BJ, Visvesvara GS (2006) In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol 53:121–126
Schuster FL, Visvesvara GS (2004) Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol 34:1001–1027
Seidel JS, Harmatz P, Visvesvara GS et al (1982) Successful treatment of primary amebic meningoencephalitis. NEJM 306:346–348
Sharma A, Raina R, Jaret P et al (2011) Primary amoebic (Naegleria fowleri) meningoencephalitis presenting as status epilepticus. Online J Health Allied Sci 10:1–2
Shojania KG, Burton EC (2008) The vanishing nonforensic autopsy. NEJM 358:873–875
Shrestha GS, Parajuli NP, Shrestha PS et al (2015) Primary amoebic meningoencephalitis. J Neurosci Rural Pract 6:284–286
Siddiqui R, Khan NA (2014) Primary amoebic meningoencephalitis caused by Naegleria fowleri: an old enemy presenting new challenges. PLoS Negl Trop Dis 8:e3017
Singh P, Kochhar R, Vashishta RK et al (2006) Amebic meningoencephalitis: spectrum of imaging findings. AJNR 27:1217–1221
Soltow SM, Brenner GM (2007) Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. Antimicrob Agents Chemother 51:23–27
Spottiswoode N, Pet D, Kim A et al (2023) Successful treatment of Balamuthia mandrillaris granulomatous amebic encephalitis with nitroxoline. Emerg Infect Dis 29:197–201
Taravaud A, Fechtali-Moute Z, Loiseau PM, Pomel S (2021) Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae. Clin Transl Sci 14:791–805
Thompson CA (2016) Hospital’s team effort helps to save boy from deadly amoebic infection. Am J Health Syst Pharm 73:1896–1898
Thong YH, Rowan-Kelly B, Ferrante A et al (1979) Treatment of experimental Naegleria meningoencephalitis with a combination of amphotericin B and rifamycin. Scand J Infect Dis 11:151–153
Tuppeny M (2011) Primary amoebic meningoencephalitis with subsequent organ procurement: a case study. J Neurosci Nurs 43:274–279
U.S. Global Change Research Program (2014) Third National Climate Assessment. http://nca2014.globalchange.gov/highlights/report-findings/our-changing-climate. Accessed 20 Dec 2023
Uy G, Lifton LC, Iller MRM et al (2001) Lack of effect of induction of hypothermia after acute brain injury. NEJM 344:556–563
Van De Beek D, De Gans J, McIntyre P, Prasad K (2007) Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev (1):CD004405
Vargas-Zepeda J, Gómez-Alcalá AV, Vázquez-Morales JA et al (2005) Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin. Arch Med Res 36:83–86
Visvesvara GS, Moura H, Schuster FL (2007) Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol 50:1–26
Wang A, Kay R, Poon WS, Ng HK (1993) Successful treatment of amoebic meningoencephalitis in a Chinese living in Hong Kong. Clin Neurol Neurosurg 95:249–252
Yoder JS, Eddy BA, Visvesvara GS et al (2010) The epidemiology of primary amoebic meningoencephalitis in the USA, 1962–2008. Epidemiol Infect 138:968–975
Zysset-Burri DC, Müller N, Beuret C et al (2014) Genome-wide identification of pathogenicity factors of the free-living amoeba Naegleria fowleri. BMC Genomics 15:1–15
Author information
Authors and Affiliations
Contributions
Ashton D. Hall: Conceptualization, Writing – original draft preparation, figs. 1 and 2, tables 1 and 2, and revisions. Julia E. Kumar: Writing – review & editing. Claire E. Golba: Writing – review & editing. Keith M. Luckett: Writing – review & editing. Whitney K. Bryant: Writing – review & editing, Supervision.
Corresponding author
Ethics declarations
Ethical approval
As this is a literature review based on publicly available data, no identifiable information was used. Therefore, ethical approval was not needed or obtained. Of note, Kali Hardig’s name and story has been widely publicized since her infection in 2013.
Consent to participate
All authors agreed to participate in this work.
Consent for publication
All authors approved the submitted version for publication.
Competing interests
None to disclose for all authors.
Additional information
Section Editor: Julia Walochnik
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hall, A.D., Kumar, J.E., Golba, C.E. et al. Primary amebic meningoencephalitis: a review of Naegleria fowleri and analysis of successfully treated cases. Parasitol Res 123, 84 (2024). https://doi.org/10.1007/s00436-023-08094-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00436-023-08094-w